Healthy subject
Showing 1 - 25 of >10,000
Healthy Trial in Vancouver (TGIR (Traditional Gastrointestinal Remedy), Placebo)
Recruiting
- Healthy
- TGIR (Traditional Gastrointestinal Remedy)
- Placebo
-
Vancouver, British Columbia, CanadaJoseph & Rosalie Segal & Family Health Centre
Mar 13, 2023
Optical Coherence Tomography, Optical Coherence Tomography Angiography Trial in Amiens (Optical coherence tomography
Recruiting
- Optical Coherence Tomography
- Optical Coherence Tomography Angiography
- Optical coherence tomography angiography
- ophthalmological exam
-
Amiens, FranceAmiens University Hospital
Sep 19, 2023
Drug Use Trial in Jakarta Pusat (Omeprazole 20 mg Capsules)
Completed
- Drug Use
- Omeprazole 20 mg Capsules
-
Jakarta Pusat, DKI Jakarta, IndonesiaPT Pharma Metric Labs
May 8, 2023
Diabetes Trial (HR011408 injection; NovoRapid®, NovoRapid®;HR011408 injection)
Not yet recruiting
- Diabetes
- HR011408 injection; NovoRapid®
- NovoRapid®;HR011408 injection
- (no location specified)
Feb 12, 2023
Drug Use Trial in Jakarta Pusat (Metformin Hydrochloride 500 MG)
Completed
- Drug Use
- Metformin Hydrochloride 500 MG
-
Jakarta Pusat, DKI Jakarta, IndonesiaPT Pharma Metric Labs
Feb 21, 2023
Healthy Volunteers Trial in Bron (Prismatic goggles, Virtual reality device)
Recruiting
- Healthy Volunteers
- Prismatic goggles
- Virtual reality device
-
Bron, FranceLyon Neuroscience Research Center
Jan 30, 2023
COVID-19 Trial in Taipei (CX-4945)
Active, not recruiting
- COVID-19
-
Taipei, TaiwanTaipei Medical University Hospital
Apr 16, 2023
Healthy Trial in Hangzhou (LPM3480392, Placebo)
Completed
- Healthy
- LPM3480392
- Placebo
-
Hangzhou, Zhejiang, ChinaThe second affiliated hosipital zhejiang university school of me
May 15, 2023
g Balance: An Examination of Postural Stability
Completed
- Postural Control, Balance, Virtual Reality, Visual
- Assessment
-
Istanbul, TurkeyYeditepe University
Nov 17, 2023
Healthy Subject Trial in Chengdu (GS3-007 oral liquid)
Not yet recruiting
- Healthy Subject
- GS3-007 oral liquid
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023
Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)
Completed
- Healthy Subject
- Neomazine Tab. 100mg
- Myungin Chlorpromazine HCl Tab. 100mg
-
Seoul, Korea, Republic ofWhan In Pharm.
Nov 23, 2023
Food Frequency Questionnaires in Estimating Food Nutrient Intake
Active, not recruiting
- Healthy Subject
- Questionnaire Administration
- +2 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Dec 9, 2022
Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)
Completed
- Healthy Subject
- CT-P41
- US-licensed Prolia
-
Seongnam, Bundang-gu, Korea, Republic of
- +1 more
Sep 7, 2023
Healthy Subject Trial in Xingtai (STSA-1002 Injection, STSA-1005 Injection)
Recruiting
- Healthy Subject
- STSA-1002 Injection
- STSA-1005 Injection
-
Xingtai, Hebei, ChinaThe Second Affiliated Hospital Of Xingtai Medical College
Nov 22, 2022
Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib
Active, not recruiting
- Healthy Subject
- Orelabrutinib and placebo (orelabrutinib tablet simulator)
- +3 more
-
Beijing, ChinaBeijing GoBroad Boren Hospital
Dec 19, 2022
Healthy Subject Trial in Chengdu (GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication)
Recruiting
- Healthy Subject
- GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication
-
Chengdu, Chengdu, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Nov 7, 2022
Diabetes in Adults Trial (HR011408 injection)
Not yet recruiting
- Diabetes in Adults
- HR011408 injection
- (no location specified)
Nov 24, 2021
Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)
Completed
- Healthy Subject
- Ursodeoxycholic Acid 250 Mg Oral Tablet
-
Seoul, Korea, Republic Of, Korea, Democratic People's Republic ofKyung Hee University Medical Hospital
Apr 16, 2023
Standardization of Test Methods and Evaluators for Testing of
Not yet recruiting
- Healthy Subject
- No drug will given
-
Gandhinagar, Gujarat, IndiaNovoBliss Research Pvt Ltd
Mar 9, 2023
IgA Nephropathy Trial in Qingdao (SHR-2010 injection, SHR-2010 injection )
Recruiting
- IgA Nephropathy
- SHR-2010 injection
- SHR-2010 injection placebo
-
Qingdao, Shandong, Chinathe Affiliated Hospital of Qingdao University
Jul 12, 2022
Healthy Subject Trial in Beijing, Xingtai (STSA-1002 Injection, Placebo)
Not yet recruiting
- Healthy Subject
- STSA-1002 Injection
- Placebo
-
Beijing, Beijing, China
- +1 more
Aug 9, 2022
Primary Sclerosing Cholangitis (PSC) Trial in Daytona Beach (CS0159)
Completed
- Primary Sclerosing Cholangitis (PSC)
-
Daytona Beach, FloridaLabcorp Clinical Research Unit, Inc.
Oct 15, 2022
Healthy Subject Trial in Shanghai (3D229, Placebo)
Completed
- Healthy Subject
- 3D229
- Placebo
-
Shanghai, Hongkou District, ChinaShanghai General hospital
Jun 20, 2022
Fluid Loss, Blood Loss Trial in Bradenton (Whole blood donation positioning)
Not yet recruiting
- Fluid Loss
- Blood Loss
- Whole blood donation positioning
-
Bradenton, FloridaSunCoast Blood Centers
Aug 3, 2023